Fox Run Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-46,089
Closed -$299K 1269
2025
Q1
$299K Sell
46,089
-3,562
-7% -$23.1K 0.05% 673
2024
Q4
$364K Buy
+49,651
New +$364K 0.07% 555
2024
Q3
Sell
-35,476
Closed -$316K 1120
2024
Q2
$316K Buy
35,476
+12,909
+57% +$115K 0.06% 543
2024
Q1
$229K Buy
+22,567
New +$229K 0.05% 601